<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04906252</url>
  </required_header>
  <id_info>
    <org_study_id>H00021832</org_study_id>
    <nct_id>NCT04906252</nct_id>
  </id_info>
  <brief_title>Vfib by ECG or Echo During Cardiac Arrest</brief_title>
  <acronym>REASON3-2021</acronym>
  <official_title>Ventricular Fibrillation and Electrocardiographic Rhythm vs Echocardiographic Rhythm During Cardiac Arrest</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Romolo Gaspari</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Temple University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Stony Brook University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Ottawa</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>ChristianaCare</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Boston Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Dartmouth College</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Alabama at Birmingham</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Rochester</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Baystate Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Medical College of Wisconsin</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Prisma Health-Midlands</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Staten Island University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>State University of New York - Upstate Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Manitoba</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kaweah Delta Health Care District</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>SBH Health System</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Yale University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The University of Texas at San Antonio</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Atrium Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Arkansas</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Valleywise Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kendall Healthcare Group, Ltd.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Truman Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Oregon Health and Science University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Vassar Brothers Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Brookdale University Hospital Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Kansas Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Maine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Colorado, Denver</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University at Buffalo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>North Shore University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hartford Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Louisiana State University Health Sciences Center in New Orleans</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Florida</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Maryland, College Park</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sutter Medical Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Arizona School of Health Sciences</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Virginia Commonwealth University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Massachusetts, Worcester</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this study is to measure survival rates associated with patients presenting in&#xD;
      cardiac arrest based on their electrocardiographic rhythm and their echocardiographic rhythm.&#xD;
      Electrocardiographic rhythm is defined as the rhythm on the ECG and echocardiographic rhythm&#xD;
      is the rhythm visualized on bedside ultrasound. Specifically, we will categorize patients&#xD;
      based on identical rhythms and dichotomous rhythms with an interest in outcomes in the&#xD;
      patient group where their echocardiographic and electrographic rhythms do not match. This is&#xD;
      important as current ACLS protocols use electrocardiographic rhythms to determine therapy but&#xD;
      limited research implies that therapeutic decisions based on echocardiographic rhythm may&#xD;
      produce increased survival.&#xD;
&#xD;
      This study will occur during emergency department resuscitation of patients presenting in&#xD;
      cardiac arrest. Patients presenting to the emergency department after cardiac arrest will&#xD;
      undergo standard resuscitation based on ACLS protocols. Ultrasound imaging will be performed&#xD;
      as soon as possible after the patient arrives and digitally recorded, as is currently the&#xD;
      standard of care at the institute. Simultaneous recording of the ECG rhythm strip will occur&#xD;
      as well. This will be repeated for as many pauses in CPR as is warranted.&#xD;
&#xD;
      Each site will record data based on the Utstein nomenclature including patient demographics,&#xD;
      arrest details and survival outcomes. Ultrasound images and ECG recordings will be&#xD;
      de-identified and submitted to a central database. Data will be uploaded into a centralized&#xD;
      database. Statistical analysis will analyze outcomes based on echocardiographic and&#xD;
      sonographic findings. Our aim is to measure the survival benefit of treating out of hospital&#xD;
      cardiac arrest using echocardiographic rhythm instead of electrocardiographic rhythm.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a multi-center, prospective, observational trial involving sites across the United&#xD;
      States and Canada. Patients will be enrolled through the emergency department either&#xD;
      presenting in cardiac arrest, or going into cardiac arrest while in the emergency department&#xD;
      after having arrested out of hospital. Advanced Cardiac Life Support (ACLS) protocols and&#xD;
      institutional policies for resuscitation will be followed, as is the current standard of&#xD;
      care. A patient encounter will conclude upon halting of cardiopulmonary resuscitation.&#xD;
      Patient outcome will be evaluated by chart review or follow-up.&#xD;
&#xD;
      Programs involved in this study must have already integrated echocardiography into Cardiac&#xD;
      Arrest clinically and have established procedures for how imaging is performed in the context&#xD;
      of CPR. Echocardiography will not hinder or impair resuscitative efforts in any way,&#xD;
      including halting CPR or prolonging pauses in CPR. Sonographic images will be obtained during&#xD;
      designated pauses in chest compressions, as is routine care, during CPR for pulse checks,&#xD;
      rhythm checks, and necessary resuscitative procedures.&#xD;
&#xD;
      Echocardiography will be performed as appropriate to obtain diagnostic information for each&#xD;
      particular patient during resuscitative efforts. Recording of the image loops will be&#xD;
      performed during image acquisition according to standard technology availability and clinical&#xD;
      protocols at each site. To facilitate image acquisition, the ultrasound probe may be placed&#xD;
      in the epigastrium or parasternal region during CPR with the heart centered in the field of&#xD;
      view, if it will not interfere with ongoing resuscitation. Recording of the images can begin&#xD;
      immediately upon pauses of CPR using whatever means are available at the site. Sonographic&#xD;
      images will be obtained by competent personnel with experience in bedside cardiac ultrasound.&#xD;
      This information will be made available to the physician taking care of the patient.&#xD;
&#xD;
      Continuous ECG tracings are displayed during cardiac arrest, and for the purpose of this&#xD;
      study recordings of these ECG tracings will need to be digitally recorded. These digital ECG&#xD;
      'rhythm strips&quot; will be matched with contemporaneous recordings of the ultrasound images of&#xD;
      the heart.&#xD;
&#xD;
      Subject data, with identifiers removed, will be uploaded into the REDcap web-based database.&#xD;
      Data will be obtained from initial patient encounter, patient records, and EMS records when&#xD;
      available.&#xD;
&#xD;
      Contemporaneous digital recordings of ultrasound images and ECG rhythm strips blinded to&#xD;
      patient identifiers will be included in a centralized database. Echocardiographic images will&#xD;
      be reviewed and interpreted by the central coordinating site blinded to patient information.&#xD;
      ECG images will be reviewed and interpreted by the central coordinating site blinded to&#xD;
      patient information.&#xD;
&#xD;
      Patient cohorts will be compared for the electrical activity by ECG and the myocardial&#xD;
      activity by echo.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 1, 2022</start_date>
  <completion_date type="Anticipated">May 1, 2025</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Survival to Hospital Admission</measure>
    <time_frame>up to 60 minutes</time_frame>
    <description>Percentage of patients who survive at the point where they are admitted to the hospital</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Rhythm Change post defibrillation</measure>
    <time_frame>up to 60 minutes</time_frame>
    <description>Percentage of patients who when defibrillated have a change in their cardiac rhythm as reflected by Electrocardiogram (ECG) report</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Return of Spontaneous Circulation (ROSC)</measure>
    <time_frame>up to 60 minutes</time_frame>
    <description>Percentage of patients who demonstrate return of spontaneous circulation (ROSC)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Survival to Hospital Discharge</measure>
    <time_frame>up to discharge, on average 7 days</time_frame>
    <description>Percentage of patients who survive at the point where they are discharged from the hospital</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ventricular Fibrillation (VFib) detected via Ultrasound but not detected via Electrocardiogram (ECG)</measure>
    <time_frame>up to 60 minutes</time_frame>
    <description>The percentage of patients with Ventricular Fibrillation (VFib)which is detected via ultrasound examination but is not detected via Electrocardiogram (ECG)</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">800</enrollment>
  <condition>Cardiac Arrest</condition>
  <arm_group>
    <arm_group_label>Ventricular Fibrillation</arm_group_label>
    <description>Patients presenting to the Emergency Department after Ventricular Fibrillation (Vfib) Cardiac Arrest or Patients demonstrating Vfib during cardiac arrest</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PEA</arm_group_label>
    <description>Patients presenting to the Emergency Department after Pulseless Electrical Activity (PEA) Cardiac Arrest. Patients demonstrating PEA during cardiac arrest</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Asystole Cardiac Arrest</arm_group_label>
    <description>Patients presenting to the Emergency Department after Asystolic Cardiac Arrest. Patients demonstrating Asystole during cardiac arrest</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Echocardiography</intervention_name>
    <description>Patients presenting in cardiac arrest will undergo echocardiography as is the standard of care at their institution</description>
    <arm_group_label>Asystole Cardiac Arrest</arm_group_label>
    <arm_group_label>PEA</arm_group_label>
    <arm_group_label>Ventricular Fibrillation</arm_group_label>
    <other_name>Ultrasound</other_name>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Electrocardiogram (ECG)</intervention_name>
    <description>Patients presenting in cardiac arrest will undergo an electrocardiogram (ECG) as is the standard of care at their institution</description>
    <arm_group_label>Asystole Cardiac Arrest</arm_group_label>
    <arm_group_label>PEA</arm_group_label>
    <arm_group_label>Ventricular Fibrillation</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients presenting after out of hospital cardiac arrest to the emergency department.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients presenting in out-of-hospital, atraumatic cardiac arrest&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Resuscitation ended due to end of life decisions&#xD;
&#xD;
          -  Documented allergy to ultrasound gel&#xD;
&#xD;
          -  Technical malfunction of ultrasound machine during imaging that prevents use&#xD;
             Ultrasound machine unable to record images&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Romolo Gaspari, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UMass Medical School</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Romolo Gaspari, MD, PhD</last_name>
    <phone>508-33-7943</phone>
    <email>Romolo.Gaspari@umassmemorial.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Dartmouth Hitchcock Medical Center</name>
      <address>
        <city>Lebanon</city>
        <state>New Hampshire</state>
        <zip>02747</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>May 24, 2021</study_first_submitted>
  <study_first_submitted_qc>May 24, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 28, 2021</study_first_posted>
  <last_update_submitted>September 30, 2021</last_update_submitted>
  <last_update_submitted_qc>September 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Massachusetts, Worcester</investigator_affiliation>
    <investigator_full_name>Romolo Gaspari</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Echocardiography</keyword>
  <keyword>Ultrasound</keyword>
  <keyword>Ventricular Fibrillation</keyword>
  <keyword>Vfib</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Arrest</mesh_term>
    <mesh_term>Ventricular Fibrillation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>As a cardiac arrest study, there is not a current plan to share individual data but this may be reconsidered if required</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

